Exploring Do-Fluoride New Materials Co., Ltd. Investor Profile: Who’s Buying and Why?

Who's buying into Do‑Fluoride New Materials Co., Ltd. (002407.SZ) and why the mix of confidence and caution matters: with a market capitalization of ¥34.03 billion and 1.16 billion shares outstanding, the company now counts institutional anchors such as China Asset Management Co., Ltd. at 12.5%, Hillhouse Capital Group at roughly 10% (after selling 2 million shares in August 2023), China Life Insurance holding 6.45%, Fidelity International boosting its stake by 15%, Qingdao Haier Capital trimming holdings by 5%, Guggenheim taking on about 3.5%, and Pictet maintaining ~3.25%-a shareholder roster that coincides with management buying back 0.85% of shares by June 30, 2025; yet the stock closed at ¥29.44 on December 12, 2025 (an 8.09% one‑day decline) against a fiscal backdrop of trailing twelve‑month revenue of ¥7.90 billion (down 30.16% YoY) and a net loss of ¥245.80 million, while analysts forecast a potential 30.9% revenue rebound in 2025-details that set the stage for why long‑term investors, strategic buyers and active managers are positioning differently and what to watch next

Do-Fluoride New Materials Co., Ltd. (002407.SZ) - Who Invests in Do-Fluoride New Materials Co., Ltd. and Why?

• China Life Insurance Co. - 6.45%: large domestic insurer allocating long-duration reserves to a growth-capable industrial name, signaling confidence in multi-year earnings expansion.
• Hillhouse Capital Group - ~10%: a major private-equity/long-only holder: sizable stake suggests strategic conviction in Do-Fluoride's technology moat and scalable production capacity.
• Fidelity International - +15% stake increase: active international manager increasing exposure, implying a view of underappreciated upside or improving fundamentals.
• Pictet Asset Management - 3.25%: steady, long-term allocation from a wealth/asset manager preferring stable growth equities.
• Guggenheim Investments - 3.5%: opportunistic institutional buyer looking for niche industrial leaders with export potential.
• Qingdao Haier Capital Co. - -5%: partial trimming consistent with portfolio rotation or capital reallocation despite continued strategic alignment.

• Exposure to specialty fluorinated chemicals used in lithium-ion battery electrolytes and high-value electronic materials.
• Perceived scalability of manufacturing and improving gross margins as capacity ramps.
• Portfolio diversification into China industrial leaders with export revenue streams.
• Active rebalancing by asset managers capturing valuation dislocations or incremental growth visibility.

Do-Fluoride New Materials Co., Ltd. (002407.SZ) Institutional Ownership and Major Shareholders of Do-Fluoride New Materials Co., Ltd. (002407.SZ)

• China Asset Management Co., Ltd. - increased stake by 3 percentage points in Q2 2023 to hold 12.5%.
• Hillhouse Capital Group - sold 2 million shares in August 2023, reducing its ownership to 10.0%.
• Qinhuai Asset Management - holds 5.5%, positioned as a long-term growth investor.
• Do-Fluoride share repurchase - company repurchased 0.85% of shares by June 30, 2025, reducing outstanding free float.

• China Asset Management's 12.5% position signals strategic accumulation - likely conviction in secular demand for fluorochemical materials and near-term growth or valuation upside.
• Hillhouse's reduction (2 million shares) to 10% appears tactical liquidity-taking rather than full exit; remaining 10% still denotes material influence and alignment with growth exposure.
• Qinhuai's 5.5% stake is consistent with long-horizon value/income orientation in specialty chemicals.
• Management-led repurchase (0.85%) both tightens float and conveys management view that shares are undervalued at prevailing prices.

Do-Fluoride New Materials Co., Ltd. (002407.SZ) Key Investors and Their Impact on Do-Fluoride New Materials Co., Ltd.

• China Asset Management Co., Ltd. - 12.5%: largest single disclosed shareholder, with direct influence on corporate governance, nomination processes and major strategic decisions.
• Hillhouse Capital Group - 10.0%: sizeable strategic investor providing industry expertise, potential board-level input and access to growth partnerships and capital markets channels.
• Qinhuai Asset Management - 5.5%: mid‑sized institutional holder aligned with long‑term strategic initiatives and stability of major projects.
• Fidelity International - 3.75%: international active manager signaling conviction in Do‑Fluoride's growth trajectory and supporting foreign investor sentiment.
• Guggenheim Investments - 3.5%: institutional investor reflecting interest from U.S./global allocators in the company's market position and technology exposure.
• Pictet Asset Management - 3.25%: steady long‑term holder adding to European institutional representation and portfolio diversification among foreign investors.

• Aggregate disclosed stake of these six investors: 38.5% - concentration that materially affects shareholder votes and strategic direction.
• Board and governance dynamics: with a 12.5% anchor holder and a 10% strategic backer, proposals for capital expenditure, joint ventures or disposal of core assets will face active scrutiny and likely require buy‑in from these holders.
• Capital markets impact: presence of Fidelity, Guggenheim and Pictet (~10.5% combined) improves international liquidity and may reduce cost of capital for cross‑border financing.
• Operational/strategic collaboration: Hillhouse's stake suggests potential for industrial partnerships, technology transfer or access to broader supply chain relationships.

Do-Fluoride New Materials Co., Ltd. (002407.SZ) - Market Impact and Investor Sentiment

• Share-price movement: on December 12, 2025 the stock fell 8.09% to 29.44 yuan, reflecting heightened short-term volatility and possible reaction to earnings or guidance.
• Share repurchase: the company repurchased 0.85% of outstanding shares by June 30, 2025, a corporate signal of management confidence in intrinsic valuation and an effort to support EPS.
• Operating performance (TTM): revenue declined 30.16% year-over-year to 7.90 billion yuan; net income was negative 245.80 million yuan, underscoring near-term margin and demand pressure.
• Capital allocation: management plans to use surplus funds to permanently supplement working capital, indicating a conservative liquidity-focused adjustment of balance-sheet policy.
• Analyst outlook: consensus projects revenue growth of 30.9% in 2025, a material recovery assumption that is likely driving interest from growth-focused and turnaround investors.

• Who's buying: institutional value investors and activist/value-oriented funds attracted by buybacks and depressed multiples; long-only equity funds and select sovereign/pension investors that price recovery scenarios; company insiders and management support via repurchases; opportunistic retail traders reacting to volatility and short-term momentum.
• Why they buy: discounted valuation after revenue decline, buyback signal of management conviction, analyst forecasts of a ~30.9% rebound in revenue for 2025, and anticipated working-capital stabilization from surplus-fund deployment.
• Risks that temper buying: ongoing negative net income (-245.80M TTM), the recent sharp one-day price drop (-8.09%), and execution risk on demand recovery assumptions.